APPLICATION
NDA016680
TYPE
NDA
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
EUTHROID-2Discontinued
LIOTRIX (T4 0.12MG, T3) 0.03MG · TABLET · ORAL
EUTHROID-0.5Discontinued
LIOTRIX (T4 0.03MG, T3) 0.0075MG · TABLET · ORAL
EUTHROID-3Discontinued
LIOTRIX (T4 0.18MG, T3) 0.045MG · TABLET · ORAL
EUTHROID-1Discontinued
LIOTRIX (T4 0.06MG, T3) 0.015MG · TABLET · ORAL
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.